Search
for
Sort by
Research 31–60 of 136
- Long-term use of 5α-reductase inhibitors and the risk of male breast cancer
- Hydroxysteroid Dehydrogenase (17β -HSD3, 17β-HSD5, and 3α-HSD3) Inhibitors:Extragonadal Regulation of Intracellular Sex Steroid Hormone Levels
- Prostate-Sparing Effects in Primates of the Potent Androgen 7α-Methyl-19-Nortestosterone: A Potential Alternative to Testosterone for Androgen Replacement and Male Contraception1
- Management of hair loss associated with endocrine therapy in patients with breast cancer: an overview
- Bioavailability File: Bicalutamide
- Hypoactive Sexual Desire and Other Sexual Dysfunctions Caused by Side Effects of Medicines Used to Treat Various Somatic Diseases and for Contraception
- Men??s Health
- 1994 Forthcoming educational events
- Redefining hormone resistance in prostate cancer
- Endocrinology of Transgender Medicine
- Emerging medication for the treatment of male hypogonadism
- Androgen Deprivation Therapy in Prostate Cancer: Focusing on Sexual Side Effects
- Androgen antagonists in androgen target tissues
- Testosterone target therapy: focus on immune response, controversies and clinical implications in patients with COVID-19 infection
- The use of cyproterone acetate/ethinyl estradiol in hyperandrogenic skin symptoms – a review
- Endocrine treatment of benign prostatichypertrophy: Current concepts
- Treatment of androgen excess in females: Yesterday, today and tomorrow
- Hyperadrenocorticism in Ferrets
- The acne hormones
- Steroid Sulfatase: Molecular Biology, Regulation, and Inhibition
- Comparison of flutamide and spironolactone in the treatment of hirsutism: a randomized controlled trial
- An Update of Congenital Adrenal Hyperplasia
- Comparison of finasteride versus flutamide in the treatment of hirsutism
- Endocrine Therapy–Induced Alopecia in Patients With Breast Cancer
- Perspectives of Kennedy's disease
- Intermittent Use of Testosterone Inactivating Pharmaceuticals Using Finasteride Prolongs the Time Off Period
- Medical Treatment of Hepatocellular Carcinoma: Any Progress?
- Hormone receptor positive, HER2 negative metastatic breast cancer: Impact of CDK4/6 inhibitors on the current treatment paradigm
- The pathophysiology of polycystic ovary syndrome: trying to understand PCOS and its endocrinology
- Pharmacology of antiandrogens